Applying Guideline-Based Care Pathways in cSCC

Panelists describe how national guidelines standardize care by integrating histopathologic criteria, imaging recommendations, and treatment algorithms. Adherence ensures consistent staging, appropriate referrals, and equitable access to advanced therapies.

They acknowledge that real-world practice can diverge from guideline intent due to limited access to specialists or regional resource variability. Continued provider education and multidisciplinary tumor boards can help bridge this gap.

Ultimately, the panel concludes that guideline-driven management ensures evidence-based decisions while allowing flexibility for individualized care, particularly for patients with complex comorbidities or recurrent disease.